Sentara recalls CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML syrups due to lack of sterility assurance. Products with a December 29-31, 2022 expiration date are affected.
Lack of sterility assurance
Sentara is recalling certain CEFAZOLIN and Heparin syrups because they may not be sterile. This could lead to infections if used improperly.
The syrups lack sterility assurance, meaning they could be contaminated with bacteria. If used, this might cause infections, especially in patients with weakened immune systems.
Patients receiving home infusion therapy using these syrups are affected. Those with the specific expiration date (December 29-31, 2022) are most at risk.
Check for the product name CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML syrups. The expiration date is December 29-31, 2022.
Look for the expiration date on the product label, which is December 29-31, 2022.
The product lacks sterility assurance, which could lead to infections if used.
The recall record does not specify a remedy, so check with Sentara Home Infusion Pharmacy Services for guidance.
The recall record does not mention serious injury risk, so the danger level is unknown.
We’ve drafted a message you can send Sentara to request your refund or repair — edit it as you like.
Subject: Recall D-0279-2023 — Sentara Sentara Hello, I own a Sentara that is covered by recall D-0279-2023 from Sentara. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
